Related references
Note: Only part of the references are listed.Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
Ardeshir R. Rastinehad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen et al.
ADVANCED MATERIALS (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
Wenfei Chen et al.
ACS NANO (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal A. Patel et al.
IMMUNITY (2018)
Oncolytic viruses prime antitumour immunity
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
How to eliminate gastric cancer-related death worldwide?
Yoshio Yamaoka
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
UROTHELIAL CANCER Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum
Jay D. Raman
NATURE REVIEWS UROLOGY (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
Xianda Zhao et al.
CANCER RESEARCH (2017)
Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy
Cheng-Hung Luo et al.
NANO LETTERS (2016)
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Ouajdi Felfoul et al.
NATURE NANOTECHNOLOGY (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Covalent Binding of Nanoliposomes to the Surface of Magnetotactic Bacteria for the Synthesis of Self-Propelled Therapeutic Agents
Samira Taherkhani et al.
ACS NANO (2014)
Differential Anticancer Drug Delivery with a Nanogel Sensitive to Bacteria-Accumulated Tumor Artificial Environment
Meng-Hua Xiong et al.
ACS NANO (2013)
Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer
Wilber Quispe-Tintaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
Chung Truong Nguyen et al.
VACCINE (2013)
Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity
Fabiana Saccheri et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
Sara Leschner et al.
PLOS ONE (2009)
Salmonella enterica serovar Gallinarum requires ppGpp for internalization and survival in animal cells
Jae-Ho Jeong et al.
JOURNAL OF BACTERIOLOGY (2008)
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer
Lucia Sfondrini et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Immune response induced by Salmonella typhimurium defective in ppGpp synthesis
HS Na et al.
VACCINE (2006)
Cancer immunotherapy based on killing of Salmonella-infected tumor cells
F Avogadri et al.
CANCER RESEARCH (2005)
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
YA Yu et al.
NATURE BIOTECHNOLOGY (2004)
Bacteriolytic therapy can generate a potent immune response against experimental tumors
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Continuous intravenous administration of live genetically modified Salmonella typhimurium in patients with metastatic melanoma
DM Heimann et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Effector and memory T-cell differentiation: Implications for vaccine development
SM Kaech et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma
JF Toso et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium
C Clairmont et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
